U.S. market Closed. Opens in 2 days 10 hours 40 minutes

MRSN | Mersana Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Revenue36.85M26.58M43.00K828.00K42.12M10.59M17.55M25.17M10.36M
Cost of Revenue148.27M927.00K132.01M67.04M55.04M59.91M928.00K32.01M21.35M
Gross Profit-111.41M25.65M-131.97M-66.21M-12.92M-49.32M16.62M-6.84M-10.99M
Operating Expenses36.85M230.35M168.90M88.94M72.32M76.25M57.16M38.99M26.70M
Selling, General & Admin59.54M56.96M36.89M21.90M17.28M16.33M10.46M6.98M5.35M
Research & Development148.27M173.38M132.01M67.04M55.04M59.91M46.70M32.01M21.35M
Other Operating ExpensesN/A-445.00K-1.20MN/AN/A1.40MN/AN/A-89.00K
Operating Income-170.96M-204.69M-169.71M-87.69M-29.22M-65.66M-39.62M-13.82M-16.34M
Other Expenses / Income-713.00K-445.00K-1.20M65.00K1.99M1.40M910.00K121.00K-87.00K
Before Tax Income-171.67M-204.21M-170.06M-88.05M-28.21M-64.26M-38.71M-13.70M-16.43M
Income Tax ExpensesN/A3.33M-855.00K359.00K-1.01M1.40MN/AN/A-2.00K
Net Income-171.67M-207.54M-169.21M-88.40M-27.20M-64.26M-38.71M-13.70M-16.43M
Interest Expenses4.07M3.33M1.27M359.00K234.00KN/AN/AN/AN/A
Basic Shares Outstanding116.11M93.65M70.58M61.49M43.40M23.03M12.02M17.49M17.49M
Diluted Shares Outstanding116.11M93.65M70.58M61.49M43.49M23.03M12.02M17.49M17.49M
EBITDA-166.08M-199.96M-167.94M-86.68M-26.73M-63.00M-37.78M-13.17M-16.04M
EBITDA Margin-450.63%-752.26%-390,553.49%-10,468.12%-63.45%-594.68%-215.33%-52.31%-154.88%
EBIT-167.60M-200.88M-168.79M-87.69M-27.97M-62.86M-38.71M-13.70M-16.43M
EBIT Margin-454.75%-755.74%-392,541.86%-10,590.10%-66.41%-593.35%-220.62%-54.43%-158.61%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙